Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre Experience

[1]  R. Seger.  Hematopoietic stem cell transplantation for chronic granulomatous disease. , 2010, Immunology and allergy clinics of North America.

[2]  H. Czajka,et al.  [Safety and efficacy of vaccination in children after stem cell transplantation. Part 1]. , 2010, Medycyna wieku rozwojowego.

[3]  A. Gennery,et al.  Unrelated donor and HLA‐identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long‐term outcome and growth , 2009, British journal of haematology.

[4]  T. Kajiume,et al.  Respiratory complications after haematopoietic stem cell transplantation in a patient with chronic granulomatous disease , 2009, Transfusion medicine.

[5]  H. Malech,et al.  Advances in treatment for chronic granulomatous disease , 2009, Immunologic research.

[6]  D. Goldblatt,et al.  Special Article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient‐based registry , 2008, Clinical and experimental immunology.

[7]  N. Okabe,et al.  Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan , 2008, European Journal of Pediatrics.

[8]  L. Notarangelo,et al.  Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. , 2008, Clinical immunology.

[9]  A. Schulz,et al.  Successful unrelated bone marrow transplantation in a child with chronic granulomatous disease complicated by pulmonary and cerebral granuloma formation , 2007, European Journal of Pediatrics.

[10]  H. Ohto,et al.  Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction , 2006, Bone Marrow Transplantation.

[11]  R. Seger,et al.  Successful Low Toxicity Hematopoietic Stem Cell Transplantation for High-Risk Adult Chronic Granulomatous Disease Patients , 2005, Transplantation.

[12]  H. Einsele,et al.  Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT , 2005, Bone Marrow Transplantation.

[13]  A. Will,et al.  Sequential reduced- and full-intensity allografting using same donor in a child with chronic granulomatous disease and coexistent, significant comorbidity , 2004, Bone Marrow Transplantation.

[14]  M. Lindemann,et al.  Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. , 2003, Blood.

[15]  A. Testi,et al.  Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature , 2003, Annals of Hematology.

[16]  A. Fischer,et al.  Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. , 2002, Blood.

[17]  G. Rechavi,et al.  Stem-cell transplantation for primary immunodeficiencies. , 2002, The Israel Medical Association journal : IMAJ.

[18]  S. Holland,et al.  Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. , 2001, The New England journal of medicine.

[19]  M. Ernst,et al.  Fas (CD95)-Fas Ligand Interactions Are Responsible for Monocyte Apoptosis Occurring as a Result of Phagocytosis and Killing of Staphylococcus aureus , 2001, Infection and Immunity.

[20]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[21]  G. Hill,et al.  The p55 TNF-α Receptor Plays a Critical Role in T Cell Alloreactivity1 , 2000, The Journal of Immunology.

[22]  G. Hill,et al.  The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity. , 2000, Journal of immunology.

[23]  A. Nagler,et al.  Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease , 1999, Bone Marrow Transplantation.

[24]  M. Dinauer,et al.  Absence of Respiratory Burst in X-linked Chronic Granulomatous Disease Mice Leads to Abnormalities in Both Host Defense and Inflammatory Response to Aspergillus fumigatus , 1997, The Journal of experimental medicine.

[25]  W. Friedrich,et al.  Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency , 1994 .

[26]  W. Friedrich,et al.  Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. , 1994, Blood.

[27]  K. Hellum.  Nitroblue tetrazolium test in bacterial and viral infections. , 1977, Scandinavian journal of infectious diseases.